资讯

Fierce Pharma18 分钟
BeOne, now a Swiss company, widens Brukinsa's BTK lead over AstraZeneca's Calquence
After beating AstraZeneca’s Calquence in quarterly revenue for the first time at the end of 2024, BeOne Medicines’ Brukinsa ...